Disease stage-dependent changes in brain levels and neuroprotective effects of neuroactive steroids in Parkinson's disease

[1]  R. Ureshino,et al.  Progestogen-Mediated Neuroprotection in Central Nervous System Disorders , 2022, Neuroendocrinology.

[2]  T. Di Paolo,et al.  Neuroactive steroids and Parkinson’s disease , 2021, Current Opinion in Endocrine and Metabolic Research.

[3]  P. Thomas,et al.  Anti-apoptotic Actions of Allopregnanolone and Ganaxolone Mediated Through Membrane Progesterone Receptors (PAQRs) in Neuronal Cells , 2020, Frontiers in Endocrinology.

[4]  L. Schneider,et al.  Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial , 2020, Alzheimer's & dementia.

[5]  D. Swaab,et al.  Alterations in the steroid biosynthetic pathways in the human prefrontal cortex in mood disorders: A post‐mortem study , 2018, Brain pathology.

[6]  M. Morissette,et al.  Effects of progesterone administered after MPTP on dopaminergic neurons of male mice , 2017, Neuropharmacology.

[7]  T. Wyss-Coray,et al.  Deficiency in Neuronal TGF-β Signaling Leads to Nigrostriatal Degeneration and Activation of TGF-β Signaling Protects against MPTP Neurotoxicity in Mice , 2017, The Journal of Neuroscience.

[8]  M. Schumacher,et al.  Steroid Profiling in Male Wobbler Mouse, a Model of Amyotrophic Lateral Sclerosis. , 2016, Endocrinology.

[9]  M. Shabani,et al.  Neurosteroid allopregnanolone attenuates cognitive dysfunctions in 6-OHDA-induced rat model of Parkinson’s disease , 2016, Behavioural Brain Research.

[10]  T. Di Paolo,et al.  Neuroprotective Effect of Progesterone in MPTP-Treated Male Mice , 2015, Neuroendocrinology.

[11]  Dave Speijer,et al.  Injury Response of Resected Human Brain Tissue In Vitro , 2015, Brain pathology.

[12]  M. Schumacher,et al.  Progesterone and allopregnanolone in the central nervous system: Response to injury and implication for neuroprotection , 2015, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  J. M. Wang.  Allopregnanolone and neurogenesis in the nigrostriatal tract , 2014, Front. Cell. Neurosci..

[14]  M. Schumacher,et al.  Revisiting the roles of progesterone and allopregnanolone in the nervous system: Resurgence of the progesterone receptors , 2014, Progress in Neurobiology.

[15]  D. Reddy,et al.  Neurosteroid interactions with synaptic and extrasynaptic GABAA receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability , 2013, Psychopharmacology.

[16]  G. Bernardi,et al.  Neurosteroid and neurotransmitter alterations in Parkinson’s disease , 2013, Frontiers in Neuroendocrinology.

[17]  R. Brinton.  Neurosteroids as regenerative agents in the brain: therapeutic implications , 2013, Nature Reviews Endocrinology.

[18]  Richard J Smeyne,et al.  Allopregnanolone Reinstates Tyrosine Hydroxylase Immunoreactive Neurons and Motor Performance in an MPTP-Lesioned Mouse Model of Parkinson's Disease , 2012, PloS one.

[19]  G. Biggio,et al.  Reduced brain levels of DHEAS in hepatic coma patients: Significance for increased GABAergic tone in hepatic encephalopathy , 2012, Neurochemistry International.

[20]  S. Bigler,et al.  Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease. , 2012, Current Alzheimer research.

[21]  D. Swaab,et al.  Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis , 2011, Neuroscience.

[22]  M. Schumacher,et al.  Steroid profiling in preeclamptic women: evidence for aromatase deficiency. , 2010, American journal of obstetrics and gynecology.

[23]  D. Swaab,et al.  Neurosteroid Biosynthetic Pathway Changes in Substantia Nigra and Caudate Nucleus in Parkinson's Disease , 2010, Brain pathology.

[24]  T. Di Paolo,et al.  Steroids‐Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders , 2010, CNS neuroscience & therapeutics.

[25]  D. Dluzen,et al.  Neuroprotective actions of sex steroids in Parkinson’s disease , 2009, Frontiers in Neuroendocrinology.

[26]  O. Wolkowitz,et al.  Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS) , 2009, Frontiers in Neuroendocrinology.

[27]  C. Kruse,et al.  Analysis of Gene Expression in Parkinson's Disease: Possible Involvement of Neurotrophic Support and Axon Guidance in Dopaminergic Cell Death , 2009, Brain pathology.

[28]  R. Verwer,et al.  Neural stem cells improve neuronal survival in cultured postmortem brain tissue from aged and Alzheimer patients , 2007, Journal of cellular and molecular medicine.

[29]  R. Irwin,et al.  Regeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent , 2007, Current Alzheimer research.

[30]  M. Robinson,et al.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention , 2007, Neurochemistry International.

[31]  M. Schumacher,et al.  Progesterone: therapeutic opportunities for neuroprotection and myelin repair. , 2007, Pharmacology & therapeutics.

[32]  M. Schumacher,et al.  Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. , 2007, Endocrine reviews.

[33]  M. Schumacher,et al.  Steroid profiling in brain and plasma of male and pseudopregnant female rats after traumatic brain injury: analysis by gas chromatography/mass spectrometry. , 2007, Endocrinology.

[34]  L. Brusa,et al.  Comparative non-radioactive RT-PCR assay: An approach to study the neurosteroids biosynthetic pathway in humans , 2006, Journal of Neuroscience Methods.

[35]  J. Lambert,et al.  Neurosteroids: endogenous regulators of the GABAA receptor , 2005, Nature Reviews Neuroscience.

[36]  R. Brinton,et al.  The Neurosteroid Allopregnanolone Promotes Proliferation of Rodent and Human Neural Progenitor Cells and Regulates Cell-Cycle Gene and Protein Expression , 2005, The Journal of Neuroscience.

[37]  D. Stein,et al.  The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. , 2005, Journal of neurotrauma.

[38]  D. Stein,et al.  Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex , 2004, Neuroscience.

[39]  M. Schumacher,et al.  Novel lipoidal derivatives of pregnenolone and dehydroepiandrosterone and absence of their sulfated counterparts in rodent brain Published, JLR Papers in Press, September 1, 2004. DOI 10.1194/jlr.M400244-JLR200 , 2004, Journal of Lipid Research.

[40]  N. Oyesiku,et al.  Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury , 2004, Experimental Neurology.

[41]  M. Oettel,et al.  Progesterone: the forgotten hormone in men? , 2004, The aging male : the official journal of the International Society for the Study of the Aging Male.

[42]  L. Garcia-Segura,et al.  Reduced Progesterone Metabolites Protect Rat Hippocampal Neurones From Kainic Acid Excitotoxicity In Vivo , 2004, Journal of neuroendocrinology.

[43]  G. Bernardi,et al.  Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson’s disease , 2003, Neurological Sciences.

[44]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[45]  R. Verwer,et al.  Post-mortem brain tissue cultures from elderly control subjects and patients with a neurodegenerative disease , 2003, Experimental Gerontology.

[46]  A. Delacourte,et al.  Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. , 2002, The Journal of clinical endocrinology and metabolism.

[47]  D. Penning,et al.  Allopregnanolone attenuates N-methyl-d-aspartate-induced excitotoxicity and apoptosis in the human NT2 cell line in culture , 2002, Neuroscience Letters.

[48]  D. Swaab,et al.  Tissue cultures from adult human postmortem subcortical brain areas , 2002, Journal of cellular and molecular medicine.

[49]  R. Verwer,et al.  Cells in human postmortem brain tissue slices remain alive for several weeks in culture , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  B. Winblad,et al.  Progesterone, 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnane-20-one in specific regions of the human female brain in different endocrine states , 1997, Brain Research.

[51]  J. A. Peters,et al.  Modulation of Human Recombinant GABAA Receptors by Pregnanediols , 1996, Neuropharmacology.

[52]  D. Caruso,et al.  Modifications of Neuroactive Steroid Levels in an Experimental Model of Nigrostriatal Degeneration: Potential Relevance to the Pathophysiology of Parkinson’s Disease , 2011, Journal of Molecular Neuroscience.

[53]  K. Krieglstein,et al.  TGF-β in Dopamine Neuron Development, Maintenance and Neuroprotection , 2009 .

[54]  M. Schumacher,et al.  Neurosteroids: beginning of the story. , 2001, International review of neurobiology.